Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.8 -0.28 (-0.72%) Market Cap: 5.66 Bil Enterprise Value: 4.94 Bil PE Ratio: 0 PB Ratio: 19.11 GF Score: 74/100

Ionis Pharmaceuticals Inc at Needham Healthcare Conference Transcript

Apr 14, 2020 / 05:30PM GMT
Release Date Price: $52.77 (+2.97%)
Chad Jason Messer
Needham & Company, LLC, Research Division - Senior Analyst

Great. Hello, everybody. My name is Chad Messer. I'm a senior biotechnology analyst here at Needham & Company. And today, it's my pleasure to be having a discussion with Brett Monia, the CEO of Ionis Pharmaceuticals. Brett, do you want to maybe start us off with a couple of opening remarks?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Sure, Chad. Thanks for the invitation. It's a pleasure to be here today. We're thrilled with where Ionis is today. We're on track to meeting all of our key corporate goals and objectives for the year, and the company has never been in a stronger position financially as well. So we're very excited about the pipeline, the technology and the financial resources that we have in place to see to it that we reach our most important goals going forward. So we're very happy where we are today.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot